Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Halozyme Therapeutic (NQ: HALO)
23.97 USD  -0.34 (-1.40%)
Official Closing Price  /  Updated: 4:25 PM EDT, May 27, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,804,332
Open 24.28
Bid (Size) 22.69 (2)
Ask (Size) 25.60 (1)
Prev. Close 24.31
Today's Range 22.53 - 24.36
52wk Range 12.71 - 25.68
Shares Outstanding 143,965,620
Dividend Yield N/A
Performance
YTD
+32.43%
+32.43%
1 Month
+2.79%
+2.79%
3 Month
+15.24%
+15.24%
6 Month
+22.73%
+22.73%
1 Year
+59.38%
+59.38%
Featured News
More News
Volatility Index signals that the bull has room to run
The Volatility Index has yet to reach complacent extremes, suggesting that the U.S. markets’ 2015 rally has room to run. Read More
category Retail , Manufacturing , Gas/Utilities , and 24 more.
from MarketWatch
Ciena Corp. jumps on earnings; PVH sinks
Ciena Corp. is up sharply on earnings while PVH Corp, which owns Calvin Klein, sinks on results. Read More
category General , HALO , Textiles and Apparel , and 20 more.
from MarketWatch
Featured News
Read More
Friday’s biggest gaining and declining stocks
category ASCA , Computer Software , NKE RIMM , and 20 more.
from MarketWatch
Friday’s biggest gaining and declining stocks
category Markets/Exchanges , VVUS , LF , and 10 more.
from MarketWatch
Thursday's biggest gaining and declining stocks
category SNTS , HALO , ATSC , and 3 more.
from MarketWatch
Drug stocks retreat with broader market
category NVS , MRK , $DRG , and 8 more.
from MarketWatch
More News
Read More
Halozyme To Receive $15 Million Milestone Payment From Janssen
from PR Newswire
Halozyme Reports First Quarter 2020 Results
from PR Newswire
Halozyme To Present At The Bank Of America Securities 2020 Healthcare Conference
from PR Newswire
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO™ Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma
from PR Newswire
Halozyme Announces Janssen's Receipt Of CHMP Positive Opinion For DARZALEX® Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma
from PR Newswire
Cramer Weighs In On Ubiquiti, Callaway Golf And More
category UI , CSCO , CDLX , and 11 more.
from Benzinga
Halozyme To Host First Quarter 2020 Financial Results Webcast and Conference Call
from PR Newswire
14 Stocks Moving In Monday's After-Hours Session
category IIVI , TME , BHF , and 17 more.
from Benzinga
EXUMA Biotech Is 'Revolutionizing CAR-T Therapy,' Increasing Patient Access, CEO Says
category Greg Frost , NVS , GILD , and 13 more.
from Benzinga
Halozyme Therapeutics Inc (HALO) Q1 2020 Earnings Call Transcript
category Market News , HALO
from Motley Fool
Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates
category IMMU , FDA , Top Stories , and 22 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.